Aerovate Therapeutics (NASDAQ:AVTE – Get Free Report) posted its earnings results on Tuesday. The company reported ($0.56) earnings per share for the quarter, beating the consensus estimate of ($0.59) by $0.03, Zacks reports.
Aerovate Therapeutics Stock Performance
Shares of NASDAQ:AVTE opened at $2.56 on Friday. Aerovate Therapeutics has a 52-week low of $1.25 and a 52-week high of $32.42. The stock’s fifty day simple moving average is $2.20 and its 200-day simple moving average is $6.31.
About Aerovate Therapeutics
Recommended Stories
- Five stocks we like better than Aerovate Therapeutics
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
- What is Short Interest? How to Use It
- Why Meta Should Rally All The Way Into 2025
Receive News & Ratings for Aerovate Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aerovate Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
